| 1 |
Singhal S, Saadeh SS, Durani U, Kansagra A, Alkhateeb HB, Shah MV, Mangaonkar A, Kenderian S, Hashmi S, Patnaik MV, Litzow MR, Hogan WJ. Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic Experience. Transplant Cell Ther 2023;29:183.e1-6. [PMID: 36584940 DOI: 10.1016/j.jtct.2022.12.016] [Reference Citation Analysis]
|
| 2 |
Mårtensson U, Nilsson S, Nolbris MJ, Wijk H, Mellgren K. Pain and discomfort in children with gastrostomy tubes - In the context of hematopoietic stem cell transplantation. J Pediatr Nurs 2023;70:79-89. [PMID: 36848740 DOI: 10.1016/j.pedn.2023.02.005] [Reference Citation Analysis]
|
| 3 |
Murzakhmetova AO, Kamkhen VB, Ainabay AM, Meiramova AM, Kemaykin VM, Ainabekova BA. Association of β<sub>2</sub> microglobulin level and glomerular filtration rate in patients with acute leukemia after hematopoietic stem cell transplantation. Ital J Med 2023. [DOI: 10.4081/itjm.2023.1563] [Reference Citation Analysis]
|
| 4 |
Kim DJ, Jeong S, Kong SG, Lee S, Lim SN, Oh SY, Do YR, Lee WS, Lee MH, Bae SH, Kim SH, Kim MK, Lee HS; Consortium for Improving Survival of Lymphoma (CISL). Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea. Sci Rep 2023;13:2551. [PMID: 36781859 DOI: 10.1038/s41598-023-27465-y] [Reference Citation Analysis]
|
| 5 |
Fried S, Shouval R, Walji M, Flynn JR, Yerushalmi R, Shem-Tov N, Danylesko I, Tomas AA, Fein JA, Devlin SM, Sauter CS, Shah GL, Kedmi M, Jacoby E, Shargian L, Raanani P, Yeshurun M, Perales MA, Nagler A, Avigdor A, Shimoni A. Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma. Transplant Cell Ther 2023;29:99-107. [PMID: 36343892 DOI: 10.1016/j.jtct.2022.10.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
González-Barrera S, Martín-Sánchez G, Parra-Jordán JJ, Fernández-Luis S, Calvo JA, Lobeira R, Yañez L, Manzano A, Carrera C, Baro J, Richard C, Bermúdez A, Ocio EM, Sanroma P. Feasibility of a Hospital-at-Home Program for Autologous Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 2023;29:111.e1-7. [PMID: 36436783 DOI: 10.1016/j.jtct.2022.11.018] [Reference Citation Analysis]
|
| 7 |
Chorão P, Montoro J, Balaguer-Roselló A, Guerreiro M, Villalba M, Facal A, Solves P, Gómez-Segui I, Pasquini MC, Granados P, Bataller A, Louro A, de la Rubia J, Sanz MA, Sanz J. T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia. Transplant Cell Ther 2023:S2666-6367(23)00037-4. [PMID: 36682469 DOI: 10.1016/j.jtct.2023.01.016] [Reference Citation Analysis]
|
| 8 |
Farshbafnadi M, Razi S, Rezaei N. Transplantation. Clinical Immunology 2023. [DOI: 10.1016/b978-0-12-818006-8.00008-6] [Reference Citation Analysis]
|
| 9 |
Eriksson LV, Holmberg K, Lundh Hagelin C, Wengström Y, Bergkvist K, Winterling J. Symptom Burden and Recovery in the First Year After Allogeneic Hematopoietic Stem Cell Transplantation. Cancer Nurs 2023;46:77-85. [PMID: 35283470 DOI: 10.1097/NCC.0000000000001077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Khan S, Siddiqui K, ElSolh H, AlJefri A, AlAhmari A, Ghemlas I, AlSaedi H, AlEnazi A, AlSeraihi A, Ayas M. Outcomes of blood and marrow transplantation in children less than 2-years of age: 23 years of experience at a single center. Int J Pediatr Adolesc Med 2022;9:190-5. [PMID: 36937328 DOI: 10.1016/j.ijpam.2022.09.002] [Reference Citation Analysis]
|
| 11 |
Poczta A, Krzeczyński P, Ionov M, Rogalska A, Gaipl US, Marczak A, Lubgan D. Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells. Int J Mol Sci 2022;23. [PMID: 36430734 DOI: 10.3390/ijms232214258] [Reference Citation Analysis]
|
| 12 |
Woelfinger P, Hauptrock B, Kriege O, List A, Schmitt T, Kuchen R, Theobald M, Wagner-Drouet EM. Pre-transplant platelet-to- lymphocyte ratio predicts outcome after allogeneic hematopoietic stem cell transplantation. Sci Rep 2022;12:18948. [PMID: 36347969 DOI: 10.1038/s41598-022-23344-0] [Reference Citation Analysis]
|
| 13 |
Dmitrova AA, Kuz'mina LA, Vasil'eva VA, Drokov MY, Parovichnikova EN. The late outcomes of syngeneic hematopoietic stem cell transplantation in patients with blood disorders. vmirvz 2022. [DOI: 10.20340/vmi-rvz.2022.5.tx.1] [Reference Citation Analysis]
|
| 14 |
Yang G, Wang X, Huang S, Huang R, Wei J, Wang X, Zhang X. Generalist in allogeneic hematopoietic stem cell transplantation for MDS or AML: Epigenetic therapy. Front Immunol 2022;13:1034438. [DOI: 10.3389/fimmu.2022.1034438] [Reference Citation Analysis]
|
| 15 |
Porras DP, Reid JC, Tanasijevic B, Golubeva D, Boyd AL, Bhatia M. Challenges in Cell Fate Acquisition to Scid-Repopulating Activity from Hemogenic Endothelium of hiPSCs Derived from AML Patients Using Forced Transcription Factor Expression. Cells 2022;11:1915. [PMID: 35741044 DOI: 10.3390/cells11121915] [Reference Citation Analysis]
|
| 16 |
Hoeben BAW, Pazos M, Seravalli E, Bosman ME, Losert C, Albert MH, Boterberg T, Ospovat I, Mico Milla S, Demiroz Abakay C, Engellau J, Jóhannesson V, Kos G, Supiot S, Llagostera C, Bierings M, Scarzello G, Seiersen K, Smith E, Ocanto A, Ferrer C, Bentzen SM, Kobyzeva DA, Loginova AA, Janssens GO. ESTRO ACROP and SIOPE recommendations for myeloablative Total Body Irradiation in children. Radiother Oncol 2022;173:119-33. [PMID: 35661674 DOI: 10.1016/j.radonc.2022.05.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Yang W, Qin M, Jia C, Yang J, Chen W, Luo Y, Jing Y, Wang B. Pediatric acute myeloid leukemia patients with KMT2A rearrangements: a single-center retrospective study. Hematology 2022;27:583-9. [PMID: 35617149 DOI: 10.1080/16078454.2022.2071797] [Reference Citation Analysis]
|
| 18 |
Snowden JA, Sánchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, Dolstra H, Duarte RF, Glass B, Greco R, Lankester AC, Mohty M, Neven B, de Latour RP, Pedrazzoli P, Peric Z, Yakoub-Agha I, Sureda A, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant 2022. [PMID: 35589997 DOI: 10.1038/s41409-022-01691-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 19 |
Seidel S, Nilius-Eliliwi V, Kowalski T, Vangala DB, Schlegel U, Schroers R. High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity. Cancers (Basel) 2022;14. [PMID: 35565230 DOI: 10.3390/cancers14092100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 20 |
Basquiera AL, Odstrcil Bobillo MS, Peroni ML, Sanchez Thomas D, Vitriu A, Berro M, Rosales Ostriz B, Milovic V, Martinez Rolón J, Jaimovich G, Hansen Krogh D, Tagliafichi V, Bisigniano L, Arbelbide JA, Giunta DH. Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI. Hematology, Transfusion and Cell Therapy 2022. [DOI: 10.1016/j.htct.2022.02.008] [Reference Citation Analysis]
|
| 21 |
José RJ, Dickey BF, Sheshadri A. Airway disease in hematologic malignancies. Expert Rev Respir Med 2022;16:303-13. [PMID: 35176948 DOI: 10.1080/17476348.2022.2043746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Karakayali EM, Önal T, Sönmez Tamer ZG, Tuğlu Mİ. Probiyotiklerin Kültürde Mezenkimal Kök Hücre Davranışına Etkisi. Balıkesir Medical Journal 2022. [DOI: 10.33716/bmedj.1038292] [Reference Citation Analysis]
|
| 23 |
Krishnamoorthi N, Prakash B, Km D, Pani CK, Ram M, Rajesh K, Dubashi B, Ganesan P, Kayal S. Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India. Indian J Med Paediatr Oncol. [DOI: 10.1055/s-0041-1740134] [Reference Citation Analysis]
|
| 24 |
Yoshimi R, Nakajima H. Current State and Issues of Regenerative Medicine for Rheumatic Diseases. Front Med 2022;9:813952. [DOI: 10.3389/fmed.2022.813952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Lüftinger R, Zubarovskaya N, Galimard J, Cseh A, Salzer E, Locatelli F, Algeri M, Yesilipek A, de la Fuente J, Isgrò A, Alseraihy A, Angelucci E, Smiers FJ, La La Nasa G, Zecca M, Fisgin T, Unal E, Kleinschmidt K, Peters C, Lankester A, Corbacioglu S; on behalf of the EBMT Pediatric Diseases, Inborn Errors Working Parties. Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major. Ann Hematol. [DOI: 10.1007/s00277-021-04732-4] [Reference Citation Analysis]
|
| 26 |
Noor A, Akhtar F, Khan S, Khan M, Akram Z, Shamshad G, Satti H, Chaudhry Q, Fatima F. Role of interleukin-6 polymorphism in acute graft-versus-host disease risk prediction in allogeneic hematopoietic stem cell transplantation. J Appl Hematol 2022;13:255. [DOI: 10.4103/joah.joah_157_21] [Reference Citation Analysis]
|
| 27 |
Vashura AY, Alymova YA. Parenteral nutritional support in children in the early period after hematopoietic stem cell transplantation: specifics and clinical aspects. Voprosy gematologii/onkologii i immunopatologii v pediatrii 2021;20:199-208. [DOI: 10.24287/1726-1708-2021-20-4-199-208] [Reference Citation Analysis]
|
| 28 |
Khanolkar RA, Faridi RM, Kinzel M, Jamani K, Savoie ML, Shafey M, Khan FM, Storek J. Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. Cytotherapy 2021:S1465-3249(21)00852-5. [PMID: 34863627 DOI: 10.1016/j.jcyt.2021.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Jasiński M, Maciejewska M, Brodziak A, Górka M, Skwierawska K, Jędrzejczak WW, Tomaszewska A, Basak GW, Snarski E. Ice-cream used as cryotherapy during high-dose melphalan conditioning reduces oral mucositis after autologous hematopoietic stem cell transplantation. Sci Rep 2021;11:22507. [PMID: 34795377 DOI: 10.1038/s41598-021-02002-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 30 |
Duque-Afonso J, Ewald S, Ihorst G, Waterhouse M, Struessmann T, Zeiser R, Wäsch R, Bertz H, Müller-Quernheim J, Duyster J, Finke J, Marks R, Engelhardt M. The impact of pulmonary function in patients undergoing autologous stem cell transplantation. Blood Adv 2021;5:4327-37. [PMID: 34610094 DOI: 10.1182/bloodadvances.2021004863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Li Y, Cheng L, Xu C, Chen J, Hu J, Liu N, Lan S, Xie J, Sun T, Wang L, Zhang Y, Sun Y, Chen S, Hu L. A Retrospective Observation of Treatment Outcomes Using Decitabine-Combined Standard Conditioning Regimens Before Transplantation in Patients With Relapsed or Refractory Acute Myeloid Leukemia. Front Oncol 2021;11:702239. [PMID: 34504785 DOI: 10.3389/fonc.2021.702239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Yang X, Li D, Xie Y. Anti-Thymocyte Globulin Prophylaxis in Patients With Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: An Updated Meta-Analysis. Front Oncol 2021;11:717678. [PMID: 34490116 DOI: 10.3389/fonc.2021.717678] [Reference Citation Analysis]
|
| 33 |
Ciavarella C, Astolfi G, Valsecchi N, Barbato F, Arpinati M, Bonifazi F, Versura P. Longitudinal Tear Protein Changes Correlate with Ocular Chronic GVHD Development in Allogeneic Hematopoietic Stem Cell Transplant Patients. Applied Sciences 2021;11:8221. [DOI: 10.3390/app11178221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 34 |
Greco R, Nitti R, Mancini N, Pasciuta R, Lorentino F, Lupo-Stanghellini MT, Barbanti MC, Clementi N, Giglio F, Clerici D, Marktel S, Assanelli A, Carrabba MG, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F. Microbiome markers are early predictors of acute GVHD in allogeneic hematopoietic stem cell transplant recipients. Blood 2021;137:1556-9. [PMID: 33171492 DOI: 10.1182/blood.2020007158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 35 |
Wang J, Duan X, Yang L, Liu X, Hao C, Dong H, Gu H, Tang H, Dong B, Zhang T, Gao G, Liang R. Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis.Cell Transplant. 2020;29:963689720975397. [PMID: 33238731 DOI: 10.1177/0963689720975397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 36 |
Pellegrini M, Bernabei F, Barbato F, Arpinati M, Giannaccare G, Versura P, Bonifazi F. Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation. Am J Ophthalmol 2021;227:25-34. [PMID: 33626365 DOI: 10.1016/j.ajo.2021.02.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 37 |
Stamm SL, Spichiger E, Pabst T, Bachnick S, Jeitziner MM. Symptom prevalence and health-related quality of life in patients undergoing autologous stem cell transplantation - A longitudinal observational study. Eur J Oncol Nurs 2021;53:101997. [PMID: 34294574 DOI: 10.1016/j.ejon.2021.101997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Xie Y, Parekh J, Tang Z, Wu D, Wu X. Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Transplant Cell Ther 2021;27:687.e1-7. [PMID: 33989833 DOI: 10.1016/j.jtct.2021.04.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Musiał K, Kałwak K, Zwolińska D. The Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Kidney Function in Children-A Single Center Experience. J Clin Med 2021;10:1113. [PMID: 33799964 DOI: 10.3390/jcm10051113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Sampaio MM, Santos MLC, Marques HS, Gonçalves VLS, Araújo GRL, Lopes LW, Apolonio JS, Silva CS, Santos LKS, Cuzzuol BR, Guimarães QES, Santos MN, de Brito BB, da Silva FAF, Oliveira MV, Souza CL, de Melo FF. Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review. World J Clin Oncol 2021; 12(2): 69-94 [PMID: 33680875 DOI: 10.5306/wjco.v12.i2.69] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 41 |
Malinowska I, Romiszewski M, Smalisz K, Stelmaszczyk-Emmel A, Nasilowska-Adamska B, Krol M, Urbanowska E, Brozyna A, Baginska-Dembowska B. Plerixafor combined with G-CSF for stem cell mobilization in children qualified for autologous transplantation- single center experience. Transfus Apher Sci 2021;60:103077. [PMID: 33583716 DOI: 10.1016/j.transci.2021.103077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Epah J, Schäfer R. Implications of hematopoietic stem cells heterogeneity for gene therapies. Gene Ther 2021. [PMID: 33589780 DOI: 10.1038/s41434-021-00229-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 43 |
Jaime-Pérez JC, Hernández-Coronado M, Picón-Galindo E, Salazar-Cavazos L, Gutiérrez-Aguirre CH, Gómez-Almaguer D. Results of a completely outpatient autologous stem cell transplant program for lymphoma patients receiving reduced-intensity conditioning. Leuk Lymphoma 2021;62:1619-28. [PMID: 33491518 DOI: 10.1080/10428194.2021.1876870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 44 |
Moret F, Marschall J, Atkinson A, Farag S, Zimmerli S, Pabst T, Sommerstein R. Characteristics of respiratory virus infections in autologous hematopoietic stem cell transplantation patients, a prospective study, Bern, Switzerland, 2015-2017. Infect Dis (Lond) 2021;53:274-80. [PMID: 33475447 DOI: 10.1080/23744235.2021.1871642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 45 |
Riham Rabie I, Ahmad Mohamed S, Mostafa Mohamed S. Stem cell therapy in children with acute liver failure: The dream could come true. Ann Clin Gastroenterol Hepatol 2021;5:001-4. [DOI: 10.29328/journal.acgh.1001024] [Reference Citation Analysis]
|
| 46 |
Apperley JF, Gratwohl A. The Role of Hematopoietic Stem Cell Transplantation in CML. Hematologic Malignancies 2021. [DOI: 10.1007/978-3-030-71913-5_11] [Reference Citation Analysis]
|
| 47 |
Khazal SJ, Ragoonanan D, Hume J, Rowan CM, Mahadeo KM. Care of the Critically Ill Pediatric Hematopoietic Cell Transplant Patient. Pediatric Critical Care 2021. [DOI: 10.1007/978-3-030-53363-2_40] [Reference Citation Analysis]
|
| 48 |
Mohamed MS, Elbadry MI, Yao C. Stem-cell therapy with bone marrow (hematopoietic) stem cells for intestinal diseases. The Intestine 2021. [DOI: 10.1016/b978-0-12-821269-1.00005-9] [Reference Citation Analysis]
|
| 49 |
Fajardo-orduña G, Chamorro-plata D. Molecular and therapeutic bases of cancer. Oncological Functional Nutrition 2021. [DOI: 10.1016/b978-0-12-819828-5.00002-4] [Reference Citation Analysis]
|
| 50 |
Hoeben BAW, Wong JYC, Fog LS, Losert C, Filippi AR, Bentzen SM, Balduzzi A, Specht L. Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions. Front Pediatr 2021;9:774348. [PMID: 34926349 DOI: 10.3389/fped.2021.774348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 51 |
Rodríguez-Lobato LG, Martínez-Roca A, Castaño-Díez S, Palomino-Mosquera A, Gutiérrez-García G, Pedraza A, Suárez-Lledó M, Rovira M, Martínez C, Fernández de Larrea C, Cibeira MT, Rosiñol L, Lozano E, Marín P, Cid J, Lozano M, Moreno-Castaño AB, Palomo M, Díaz-Ricart M, Gallego C, Hernando A, Segura S, Carreras E, Urbano-Ispizua Á, Bladé J, Fernández-Avilés F. The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever. PLoS One 2020;15:e0241778. [PMID: 33147257 DOI: 10.1371/journal.pone.0241778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 52 |
Antar AI, Otrock ZK, Abou Dalle I, El-Cheikh J, Bazarbachi A. Pharmacologic Therapies to Prevent Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Front Oncol 2020;10:596134. [PMID: 33224890 DOI: 10.3389/fonc.2020.596134] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 53 |
Jahnz-RÓŻyk K, WiĘsik-Szewczyk E, RoliŃski J, Siedlar M, JĘdrzejczak W, Sydor W, Tomaszewska A. Secondary immunodeficiencies with predominant antibody deficiency: multidisciplinary perspectives of Polish experts. Cent Eur J Immunol 2020;45:334-41. [PMID: 33437186 DOI: 10.5114/ceji.2020.101265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 54 |
Garming Legert K, Ringdén O, Remberger M, Törlén J, Mattsson J, Dahllöf G. Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis. Oral Dis 2021;27:1217-25. [PMID: 33012083 DOI: 10.1111/odi.13663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 55 |
Yeral M, Aytan P, Gungor B, Boga C, Unal A, Koc Y, Kaynar L, Buyukkurt N, Eser B, Ozdoğu H. A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity. Clinical Lymphoma Myeloma and Leukemia 2020;20:652-60. [DOI: 10.1016/j.clml.2020.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 56 |
Kliman D, Nivison-smith I, Gottlieb D, Hamad N, Kerridge I, Purtill D, Szer J, Ma D. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation. Biology of Blood and Marrow Transplantation 2020;26:1711-8. [DOI: 10.1016/j.bbmt.2020.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Montes de Oca C, Castagna L, De Philippis C, Bramanti S, Schiano JM, Pagliardini T, Collignon A, Harbi S, Mariotti J, Granata A, Maisano V, Furst S, Legrand F, Chabannon C, Carlo-Stella C, Santoro A, Blaise D, Devillier R. Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas. Biol Blood Marrow Transplant 2020;26:2299-305. [PMID: 32822845 DOI: 10.1016/j.bbmt.2020.08.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 58 |
de Melo Rodrigues AL, Bonfim C, Seber A, Colturato VAR, Zecchin VG, Nichele S, Daudt LE, Fernandes JF, Vieira AK, Darrigo Junior LG, Gomes AA, Arcuri L, Lenzi L, Picharski GL, Ribeiro RC, de Figueiredo BC. Allogeneic Hematopoietic Stem Cell Transplantation for Children and Adolescents with Acute Myeloid Leukemia in Brazil: A Multicentric Retrospective Study. Cell Transplant 2020;29:963689720949175. [PMID: 32787568 DOI: 10.1177/0963689720949175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 59 |
Pellegrini M, Giannaccare G, Bernabei F, Moscardelli F, Sessa M, Arpinati M, Bonifazi F, Versura P. Longitudinal Corneal Endothelial Cell Changes in Patients Undergoing Hematopoietic Stem Cell Transplantation. Cornea 2021;40:462-6. [PMID: 32732696 DOI: 10.1097/ICO.0000000000002441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 60 |
Martínez C, Boumendil A, Romejko-Jarosinska J, Anagnostopoulos A, Faber E, Poiré X, Yakoub-Agha I, Akhtar S, Gurman G, Pavone V, Halaburda K, Sousa AB, Ghesquières H, Finel H, Khvedelidze I, Montoto S, Sureda A. Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT. Leuk Lymphoma 2020;61:2915-22. [PMID: 32654552 DOI: 10.1080/10428194.2020.1789624] [Reference Citation Analysis]
|
| 61 |
Zając-Spychała O, Zaucha-Prażmo A, Zawitkowska J, Wachowiak J, Kowalczyk JR, Frączkiewicz J, Salamonowicz M, Kałwak K, Gorczyńska E, Chybicka A, Czyżewski K, Dziedzic M, Wysocki M, Zalas-Więcek P, Goździk J, Styczyński J. Infectious complications after hematopoietic stem cell transplantation for primary immunodeficiency in children: A multicenter nationwide study. Pediatr Allergy Immunol 2020;31:537-43. [PMID: 32150770 DOI: 10.1111/pai.13239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 62 |
Truong TH, Pole JD, Bittencourt H, Schechter T, Cuvelier GDE, Paulson K, Rayar M, Mitchell D, Schultz KR, O'Shea D, Barber R, Sung L. Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemia. Pediatr Blood Cancer 2020;67:e28263. [PMID: 32323913 DOI: 10.1002/pbc.28263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 63 |
Culos KA, Gatwood KS, Byrne M. Maintenance Strategies After Hematopoietic Cell Transplantation. Pharmacotherapy 2020;40:727-40. [PMID: 32343426 DOI: 10.1002/phar.2407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 64 |
Iftikhar R, Chaudhry QUN, Satti TM, Mahmood SK, Ghafoor T, Shamshad GU, Shahbaz N, Khan MA, Khattak TA, Rehman J, Farhan M, Humayun S, Haq H, Naqvi SAA, Anwer F, Satti HS, Ahmed P. Comparison of Conventional Cyclophosphamide versus Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor Transplantation. Clin Hematol Int 2020;2:82-91. [PMID: 34595447 DOI: 10.2991/chi.d.200426.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 65 |
Greco-Stewart V, Elmoazzen H, Morris G, Guo Y, Langdon C, Mercer D, Dibdin N, Allan DS. Improved access to better HLA-matched hematopoietic cells for allogeneic transplant: analysis of donors and cord blood units selected for Canadian patients in 2018. Transfusion 2020;60:1508-18. [PMID: 32319688 DOI: 10.1111/trf.15795] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 66 |
Boehlen R, Fernandez P, Bargetzi M, Sigle JP. A new protocol for improving efficiency of autologous peripheral blood stem cell collection in patients with high white blood cell counts. J Clin Apher 2020;35:217-23. [PMID: 32304598 DOI: 10.1002/jca.21782] [Reference Citation Analysis]
|
| 67 |
Crocchiolo R, Cornacchini G, Lando G, Coviello A, Cuppari I, Volpato E, Pugliano MT, Grillo G, Zucchetti E, Rossini S. The number of HLA confirmatory tests during unrelated donor search as a driver for the evaluation of back-up haploidentical donor(s). Transfus Apher Sci 2020;59:102766. [PMID: 32276862 DOI: 10.1016/j.transci.2020.102766] [Reference Citation Analysis]
|
| 68 |
Rodríguez-Lobato LG, Martínez-Roca A, Moreno DF, Gutiérrez-García G, Suárez-Lledó M, Rovira M, Martínez C, Rosiñol L, Almeida Jorge AS, Pedraza A, Cardozo C, Puerta-Alcalde P, Garcia-Vidal C, Marín P, Cid J, Lozano M, Gallego C, Hernando A, Segura S, Urbano-Ispizua Á, Fernández-Avilés F. Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients. Leuk Lymphoma 2020;61:1565-74. [PMID: 32208787 DOI: 10.1080/10428194.2020.1742901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 69 |
Dreger P, Sureda A, Ahn KW, Eapen M, Litovich C, Finel H, Boumendil A, Gopal A, Herrera AF, Schmid C, Diez-Martin JL, Fuchs E, Bolaños-Meade J, Gooptu M, Al Malki MM, Castagna L, Ciurea SO, Dominietto A, Blaise D, Ciceri F, Tischer J, Corradini P, Montoto S, Robinson S, Gülbas Z, Hamadani M. PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL. Blood Adv 2019;3:360-9. [PMID: 30723110 DOI: 10.1182/bloodadvances.2018027748] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 70 |
Poiré X, Labopin M, Polge E, Volin L, Finke J, Ganser A, Blaise D, Yakoub-Agha I, Beelen D, Forcade E, Lioure B, Socié G, Niederwieser D, Labussière-Wallet H, Maertens J, Cornelissen J, Craddock C, Mohty M, Esteve J, Nagler A. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation. Am J Hematol 2020;95:282-94. [PMID: 31876307 DOI: 10.1002/ajh.25714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 71 |
Vassilakopoulos TP, Asimakopoulos JV, Konstantopoulos K, Angelopoulou MK. Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies. Ther Adv Hematol 2020;11:2040620720902911. [PMID: 32110285 DOI: 10.1177/2040620720902911] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 72 |
Wang T, Ma LM, Zhu QJ, Gong R, Gao ZL, Tian WW. [Clinical analysis of the timing and efficacy of allogeneic stem cell transplantation for severe aplastic anemia with infections]. Zhonghua Xue Ye Xue Za Zhi 2019;40:959-61. [PMID: 31856449 DOI: 10.3760/cma.j.issn.0253-2727.2019.11.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 73 |
Kanate AS, Kumar A, Dreger P, Dreyling M, Le Gouill S, Corradini P, Bredeson C, Fenske TS, Smith SM, Sureda A, Moskowitz A, Friedberg JW, Inwards DJ, Herrera AF, Kharfan-Dabaja MA, Reddy N, Montoto S, Robinson SP, Abutalib SA, Gisselbrecht C, Vose J, Gopal A, Shadman M, Perales MA, Carpenter P, Savani BN, Hamadani M. Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT. JAMA Oncol 2019;5:715-22. [PMID: 30816957 DOI: 10.1001/jamaoncol.2018.6278] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 74 |
Miranda-Silva W, Knebel FH, Tozetto-Mendozo TR, Palmieri M, da Fonseca FP, Camargo AA, Braz-Silva PH, Fregnani ER. Herpesviruses in the oral cavity of patients subjected to allogeneic hematopoietic stem cell transplantation and its relationship with oral mucositis. Clin Oral Investig 2020;24:3597-608. [PMID: 32036434 DOI: 10.1007/s00784-020-03234-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 75 |
Pagel JM, Othus M, Garcia-Manero G, Fang M, Radich JP, Rizzieri DA, Marcucci G, Strickland SA, Litzow MR, Savoie ML, Spellman SR, Confer DL, Chell JW, Brown M, Medeiros BC, Sekeres MA, Lin TL, Uy GL, Powell BL, Bayer RL, Larson RA, Stone RM, Claxton D, Essell J, Luger SM, Mohan SR, Moseley A, Erba HP, Appelbaum FR. Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia. JCO Oncol Pract 2020;16:e464-75. [PMID: 32048933 DOI: 10.1200/JOP.19.00133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Sharin UBM, Hwang CCJ, Ang WHD, Lopez V. The haematopoietic stem cell transplant survivors' sense of coherence about their experiences: a qualitative study. Support Care Cancer 2020;28:4275-83. [PMID: 31900616 DOI: 10.1007/s00520-019-05273-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 77 |
Drokov MY, Dmitrova A, Kuzmina L, Vasil’eva V, Mikhaltsova E, Koroleva O, Usikova E, Parovichnikova E, Savchenko V. Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation. Клиническая онкогематология 2020;13:89-94. [DOI: 10.21320/2500-2139-2020-13-1-89-94] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 78 |
von Wolff M, Gökbuget N, Jarisch A. Acute Leukaemia. Fertility Preservation in Oncological and Non-Oncological Diseases 2020. [DOI: 10.1007/978-3-030-47568-0_8] [Reference Citation Analysis]
|
| 79 |
Im A, Pavletic SZ. Hematopoietic Stem Cell Transplantation. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00028-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 80 |
Karlas T. Role of Liver Stiffness in Hematological Disorders: Assessment of Sinusoidal Obstruction Syndrome, Budd–Chiari Syndrome, and Treatment Complications. Liver Elastography 2020. [DOI: 10.1007/978-3-030-40542-7_14] [Reference Citation Analysis]
|
| 81 |
Qin Z, Huang Q, Zou J, Tang L, Hu Z, Tang X. Progress in Hematopoietic Stem Cell Transplantation for CIDP. Int J Med Sci 2020;17:234-41. [PMID: 32038107 DOI: 10.7150/ijms.38363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 82 |
Hutchings M, Ladetto M, Buske C, de Nully Brown P, Ferreri AJM, Pfreundschuh M, Schmitz N, Balari AS, van Imhoff G, Walewski J; ESMO Lymphoma Consensus Conference Panel Members. ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients. Ann Oncol 2018;29:1687-700. [PMID: 29924296 DOI: 10.1093/annonc/mdy167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 83 |
Töret E, Adalı Aksoy B, Çavuş G, Aydoğdu S, Çipe F, Dikme G, Tunç Y, Fışgın T, Bozkurt C. Beslenme desteği tipi hematopoetik kök hücre nakil sonuçlarını etkiliyor mu? Bir pediatrik merkez deneyimi. Ege Tıp Bilimleri Dergisi 2019;2:119-123. [DOI: 10.33713/egetbd.644105] [Reference Citation Analysis]
|
| 84 |
Balassa K, Danby R, Rocha V. Haematopoietic stem cell transplants: principles and indications. Br J Hosp Med (Lond) 2019;80:33-9. [PMID: 30592675 DOI: 10.12968/hmed.2019.80.1.33] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 85 |
Liao NC, Shih YL, Ho MT, Lu TJ, Lee CH, Peng SF, Leu SJ, Chung JG. Cardamonin induces immune responses and enhances survival rate in WEHI-3 cell-generated mouse leukemia in vivo. Environ Toxicol 2020;35:457-67. [PMID: 31793136 DOI: 10.1002/tox.22881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 86 |
Zaucha-Prażmo A, Zawitkowska J, Lejman M, Kowalczyk JR, Czyżewski K, Dziedzic M, Pieczonka A, Zając-Spychała O, Goździk J, Frączkiewicz J, Salamonowicz M, Gorczyńska E, Kałwak K, Wachowiak J, Styczyński J. Infection profile in children and adolescents with bone marrow failures treated with allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 2019;23:e13592. [PMID: 31587440 DOI: 10.1111/petr.13592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 87 |
Yang Y, Xu H, He H, Qi J, Yan J, Wang N, Huang D. Combination of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation With Unrelated Cord Blood Unit in Patients Aged 35 to 50 Years With Severe Aplastic Anemia: Preliminary Summary of a Single-Arm Trial. Transplant Proc 2019;51:3431-6. [PMID: 31733793 DOI: 10.1016/j.transproceed.2019.07.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 88 |
Tremblay G, Said Q, Roy AN, Cai B, Ashton Garib S, Hearnden J, Forsythe A. Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States. Clinicoecon Outcomes Res 2019;11:673-81. [PMID: 31814747 DOI: 10.2147/CEOR.S226323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 89 |
Domingo-Domènech E, Boumendil A, Climent F, Sengeloev H, Wahlin B, Wattad W, Arat M, Finel H, Schapp N, Ganser A, Yeshurun M, Pavone V, Snowden J, Finke J, Montoto S, Sureda A, Dreger P; Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT. Bone Marrow Transplant 2020;55:796-803. [PMID: 31695174 DOI: 10.1038/s41409-019-0734-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 90 |
Arrieta-bolaños E, Oliveira DC, Barquera R. Differential admixture, human leukocyte antigen diversity, and hematopoietic cell transplantation in Latin America: challenges and opportunities. Bone Marrow Transplant 2020;55:496-504. [DOI: 10.1038/s41409-019-0737-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 91 |
Bueno JL, Alegre A, López-villar O, Querol S, Arroyo JL, Goterris R, Sureda A, García-gala JM, Amunarriz C, Albo C, Fernández-fuertes F, Medina L, Antelo ML, Blanquer M, Vallejo C, Canales M, Vidales-mancha I, Duarte RF. Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document. Bone Marrow Transplant 2020;55:811-7. [DOI: 10.1038/s41409-019-0716-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 92 |
Greco R, Lorentino F, Nitti R, Lupo Stanghellini MT, Giglio F, Clerici D, Xue E, Lazzari L, Piemontese S, Mastaglio S, Assanelli A, Marktel S, Corti C, Bernardi M, Ciceri F, Peccatori J. Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide. Front Immunol 2019;10:2319. [PMID: 31632401 DOI: 10.3389/fimmu.2019.02319] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 93 |
González-barca E, Boumendil A, Blaise D, Trněný M, Masszi T, Finel H, Michieli MG, Bittenbring JT, Gritti G, Snowden JA, Bishton M, Bruno B, de Villambrosia SG, Janikova A, Leleu X, Anagnostopoulos A, Poiré X, Crysandt M, Özkurt ZN, Vandenberghe E, Itälä-remes M, Cahn JY, Jantunen E, Schroyens W, Maertens J, Esquirol A, Dreger P, Montoto S, Sureda A. Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2020;55:393-9. [DOI: 10.1038/s41409-019-0650-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 94 |
Xu J, Zhao R, Yang L, Gong H, Ma S, Chen J, Liu H, Shen H, Zhu M, Chen S, Ma X, Wu X, Wu D. Haploidentical stem cells combined with a small dose of umbilical cord blood transplantation exert similar survival outcome of HLA-matched stem cells transplantation in T-cell acute lymphoblastic leukemia. Bone Marrow Transplant 2020;55:1197-9. [PMID: 31488878 DOI: 10.1038/s41409-019-0666-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 95 |
Fürst D, Neuchel C, Tsamadou C, Schrezenmeier H, Mytilineos J. HLA Matching in Unrelated Stem Cell Transplantation up to Date. Transfus Med Hemother 2019;46:326-36. [PMID: 31832058 DOI: 10.1159/000502263] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 96 |
Gorin N. Hématologie et thérapie cellulaire. Historique de l’autogreffe de cellules souches hématopoïétiques : rôle actuel en hématologie. Nouveautés pour le traitement des leucémies aiguës myéloblastiques de l’adulte. Bulletin de l'Académie Nationale de Médecine 2019;203:462-470. [DOI: 10.1016/j.banm.2019.03.025] [Reference Citation Analysis]
|
| 97 |
Hacker ED. Physical Activity and Exercise Adherence in People With Hematologic Malignancies. The Journal for Nurse Practitioners 2019;15:568-73. [DOI: 10.1016/j.nurpra.2019.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 98 |
Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S, Mikulska M, Gil L, Cordonnier C, Ljungman P, Averbuch D, Cesaro S, de la Camara R, Baldomero H, Bader P, Basak G, Bonini C, Duarte R, Dufour C, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Kröger N, Mohty M, Gratwohl A; Infectious Diseases Working Party EBMT. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant 2020;55:126-36. [PMID: 31455899 DOI: 10.1038/s41409-019-0624-z] [Cited by in Crossref: 105] [Cited by in F6Publishing: 113] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 99 |
Halaburda K, Labopin M, Mailhol A, Socié G, Craddock C, Aljurf M, Beelen D, Cornelissen JJ, Bourhis JH, Labussière-Wallet H, Blaise D, Gedde-Dahl T, Gilleece M, Yakoub-Agha I, Mufti G, Esteve J, Mohty M, Nagler A. Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica 2020;105:1723-30. [PMID: 31439677 DOI: 10.3324/haematol.2019.222810] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 100 |
Shem-tov N, Peczynski C, Labopin M, Itälä-remes M, Blaise D, Labussière-wallet H, Socié G, Kröger N, Mielke S, Afanasyev B, Chevallier P, Tischer J, Helbig G, Jindra P, Peric Z, Giebel S, Mohty M, Nagler A. Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT. Leukemia 2020;34:283-92. [DOI: 10.1038/s41375-019-0544-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 101 |
Dima F, Barison E, Midolo M, Benedetti F, Lippi G. Assessment of haematopoietic progenitor cell counting with the Sysmex® XN-1000 to guide timing of apheresis of peripheral blood stem cells. Blood Transfus 2020;18:67-76. [PMID: 31403932 DOI: 10.2450/2019.0086-19] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 102 |
Evans JC, Hirani SP, Needle JJ. Nutritional and Post-Transplantation Outcomes of Enteral versus Parenteral Nutrition in Pediatric Hematopoietic Stem Cell Transplantation: A Systematic Review of Randomized and Nonrandomized Studies. Biology of Blood and Marrow Transplantation 2019;25:e252-9. [DOI: 10.1016/j.bbmt.2019.02.023] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 103 |
Novelli S, Monter A, Pilar García-Muret M, Martino R, Briones J, Sierra J. Discussion on the indication of allogeneic stem cell transplantation for advanced cutaneous T cell lymphomas. Int J Hematol 2019;110:406-10. [PMID: 31317515 DOI: 10.1007/s12185-019-02707-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 104 |
Zaucha-Prażmo A, Sadurska E, Pieczonka A, Goździk J, Dębski R, Drabko K, Zawitkowska J, Lejman M, Wachowiak J, Styczyński J, Kowalczyk JR. Risk Factors for Transplant Outcomes in Children and Adolescents with Non-Malignant Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation. Ann Transplant 2019;24:374-82. [PMID: 31235684 DOI: 10.12659/AOT.915330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 105 |
Appelbaum JS, Milano F. Hematopoietic Stem Cell Transplantation in the Era of Engineered Cell Therapy. Curr Hematol Malig Rep 2018;13:484-93. [PMID: 30280289 DOI: 10.1007/s11899-018-0476-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 106 |
Evans J, Needle JJ, Hirani SP. Early outcomes of gastrostomy feeding in paediatric allogenic bone marrow transplantation: A retrospective cohort study. Clinical Nutrition ESPEN 2019;31:71-9. [DOI: 10.1016/j.clnesp.2019.02.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 107 |
Truong TH, Pole JD, Bittencourt H, Schechter T, Cuvelier GD, Paulson K, Rayar M, Mitchell D, Schultz KR, O'shea D, Barber R, Wall D, Sung L. Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis. Biology of Blood and Marrow Transplantation 2019;25:1172-8. [DOI: 10.1016/j.bbmt.2019.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 108 |
Dietrich S, Dreger P, Hermine O, Kyriakou C, Montoto S, Robinson S, Schmitz N, Schouten HC, Sureda A, Tanase A. Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation. Bone Marrow Transplant 2020;55:317-24. [DOI: 10.1038/s41409-019-0583-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 109 |
Roy DC, Lachance S, Cohen S, Delisle JS, Kiss T, Sauvageau G, Busque L, Ahmad I, Bernard L, Bambace N, Boumédine RS, Guertin MC, Rezvani K, Mielke S, Perreault C, Roy J. Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis. Br J Haematol 2019;186:754-66. [PMID: 31135970 DOI: 10.1111/bjh.15970] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 110 |
Marsh JCW, Risitano AM, Mufti GJ. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia. Biol Blood Marrow Transplant 2019;25:e277-84. [PMID: 31129354 DOI: 10.1016/j.bbmt.2019.05.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 111 |
Liao N, Shih Y, Chou J, Chen K, Chen Y, Lee M, Peng S, Leu S, Chung J. Cardamonin Induces Cell Cycle Arrest, Apoptosis and Alters Apoptosis Associated Gene Expression in WEHI-3 Mouse Leukemia Cells. Am J Chin Med 2019;47:635-56. [DOI: 10.1142/s0192415x19500332] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 112 |
Sorigue M, Sancho J. Recent landmark studies in follicular lymphoma. Blood Reviews 2019;35:68-80. [DOI: 10.1016/j.blre.2019.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 113 |
Balassa K, Salisbury R, Watson E, Lubowiecki M, Tseu B, Maouche N, Jeffery K, Misbah SA, Benamore R, Rowley L, Barton D, Pawson R, Danby R, Rocha V, Peniket A. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation. J Infect 2019;78:461-7. [PMID: 30965067 DOI: 10.1016/j.jinf.2019.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 114 |
Duarte RF, Labopin M, Bader P, Basak GW, Bonini C, Chabannon C, Corbacioglu S, Dreger P, Dufour C, Gennery AR, Kuball J, Lankester AC, Lanza F, Montoto S, Nagler A, Peffault de Latour R, Snowden JA, Styczynski J, Yakoub-Agha I, Kröger N, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant 2019;54:1525-52. [PMID: 30953028 DOI: 10.1038/s41409-019-0516-2] [Cited by in Crossref: 148] [Cited by in F6Publishing: 154] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 115 |
Versluis J, Cornelissen JJ. Risks and benefits in a personalized application of allogeneic transplantation in patients with AML in first CR. Seminars in Hematology 2019;56:164-70. [DOI: 10.1053/j.seminhematol.2018.08.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 116 |
Kao RL, Holtan SG. Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell Transplantation. Infect Dis Clin North Am 2019;33:311-29. [PMID: 30940461 DOI: 10.1016/j.idc.2019.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 117 |
Flis S, Chojnacki T. Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities. Drug Des Devel Ther. 2019;13:825-843. [PMID: 30880916 DOI: 10.2147/dddt.s191303] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 118 |
Jantunen E, Varmavuo V, Pelkonen J, Valtola J. Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients. Leuk Lymphoma 2019;60:2115-21. [PMID: 30843749 DOI: 10.1080/10428194.2019.1581929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 119 |
Karlas T, Weiße T, Petroff D, Beer S, Döhring C, Gnatzy F, Niederwieser D, Behre G, Mössner J, Fischer J, Tröltzsch M, Wiegand J, Keim V, Franke G. Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement. Bone Marrow Transplant 2019;54:1738-46. [DOI: 10.1038/s41409-019-0464-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 120 |
Hübel K, Re A, Boumendil A, Finel H, Hentrich M, Robinson S, Wyen C, Michieli M, Kanfer E, Diez-Martin JL, Balsalobre P, Vincent L, Schroyens W, Santasusana JMR, Kröger N, Schiel X, Cwynarski K, Esquirol A, Sousa AB, Cattaneo C, Montoto S, Dreger P. Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party. Bone Marrow Transplant 2019;54:1625-31. [PMID: 30804486 DOI: 10.1038/s41409-019-0480-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 121 |
Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant 2019;54:1575-85. [PMID: 30728439 DOI: 10.1038/s41409-019-0465-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 25.5] [Reference Citation Analysis]
|
| 122 |
Johansson JE, Bratel J, Hardling M, Heikki L, Mellqvist UH, Hasséus B. Cryotherapy as prophylaxis against oral mucositis after high-dose melphalan and autologous stem cell transplantation for myeloma: a randomised, open-label, phase 3, non-inferiority trial. Bone Marrow Transplant 2019;54:1482-8. [PMID: 30718802 DOI: 10.1038/s41409-019-0468-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 123 |
Varlet P, Rogeau S, Trauet J, Demaret J, Labalette M. Immunomagnetic selective donor-derived CD4+CCR7+ T cell depletion procedure for peripheral blood stem cells graft. Current Research in Translational Medicine 2019;67:1-7. [DOI: 10.1016/j.retram.2018.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 124 |
Abuelgasim KA, Alzahrani M, Alsharhan Y, Khairi M, Hommady M, Gmati G, Salama H, Ali O, Alahmari B, Masuadi EM, Alaskar A, Alhejazi A, Damlaj M. Chemoimmunotherapy with brentuximab vedotin combined with ifosfamide, gemcitabine, and vinorelbine is highly active in relapsed or refractory classical Hodgkin lymphoma. Bone Marrow Transplant 2019;54:1168-72. [PMID: 30700792 DOI: 10.1038/s41409-019-0454-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 125 |
Poirel HA, Vanspauwen M, Macq G, De Geyndt A, Maertens J, Willems E, Selleslag D, Poiré X, Theunissen K, Graux C, Kerre T, Zachée P, Meuleman N, De Becker A, Verlinden A, Van Obbergh F, Schuermans C, De Wilde V, Jaspers A, Pranger D, Deeren D, Van Riet I, Vaes E, Beguin Y; Belgian Transplant Registry and the Belgian Haematological Society’s Transplant committee. Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres. Bone Marrow Transplant 2019;54:1434-42. [PMID: 30696999 DOI: 10.1038/s41409-019-0458-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 126 |
Budaeva IG, Girshova L, Ovsyannikova E, Goryunova E, Kulemina O, Zaitsev D, Motorin D, Badaev R, Zammoeva D, Ivanov V, Bogdanov K, Pisotskaya O, Mirolyubova Y, Nikulina T, Alekseeva Y, Zaritskey A. Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/ Refractory Acute Myeloid Leukemia. Клиническая онкогематология 2019;12:289-296. [DOI: 10.21320/2500-2139-2019-12-3-289-296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 127 |
Samarasinghe S, Clesham K, Iacobelli S, Sbianchi G, Knol C, Hamladji RM, Socié G, Aljurf M, Koh M, Sengeloev H, Dalle JH, Robinson S, Van Lint MT, Halkes CJM, Beelen D, Mufti GJ, Snowden J, Blaise D, de Latour RP, Marsh J, Dufour C, Risitano AM; Severe Aplastic Anaemia Working Party of the EBMT. Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working party. Am J Hematol 2019;94:80-6. [PMID: 30328134 DOI: 10.1002/ajh.25314] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 128 |
Schmitz N, Stelljes M, Bazarbachi A. Diffuse Large B-Cell Lymphoma. The EBMT Handbook 2019. [DOI: 10.1007/978-3-030-02278-5_85] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 129 |
Johnston L. Bone Marrow Malignancies and Indications for Hematopoietic Cell Transplantation. Psychosocial Care of End-Stage Organ Disease and Transplant Patients 2019. [DOI: 10.1007/978-3-319-94914-7_37] [Reference Citation Analysis]
|
| 130 |
Rudakova TA, Kulagin A, Klimova O, Golubovskaya I, Darskaya E, Bykova T, Smirnova A, Morozova E, Bondarenko S, Moiseev I, Beynarovich A, Pevtsov D, Alyanskii A, Babenko E, Barkhatov I, Afanas'ev B. Severe "Poor Graft Function" after Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients: Incidence, Risk Factors, and Outcomes. Клиническая онкогематология 2019;12:309-318. [DOI: 10.21320/2500-2139-2019-12-3-309-318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 131 |
Shaw BE. Patient and Donor Selection and Workup for Hematopoietic Cell Transplantation. Hematopoietic Cell Transplantation for Malignant Conditions 2019. [DOI: 10.1016/b978-0-323-56802-9.00006-7] [Reference Citation Analysis]
|
| 132 |
Tewari P, Bajwa R, Taraseviciute A, Moffet J, Mccall D, Mahadeo KM. Hematopoietic Stem Cell Transplant and Cellular Therapy. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient 2019. [DOI: 10.1007/978-3-030-01322-6_8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 133 |
Duarte RF, Sánchez-ortega I. HSCT in Elderly Patients. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook. Cham: Springer International Publishing; 2019. pp. 499-503. [DOI: 10.1007/978-3-030-02278-5_68] [Reference Citation Analysis]
|
| 134 |
Ladenstein R, Glogova E, Lanza F. Solid Tumours. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook. Cham: Springer International Publishing; 2019. pp. 685-98. [DOI: 10.1007/978-3-030-02278-5_92] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 135 |
Babic A, Murray J. Role of Nursing in HSCT. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook. Cham: Springer International Publishing; 2019. pp. 237-43. [DOI: 10.1007/978-3-030-02278-5_32] [Reference Citation Analysis]
|
| 136 |
Sureda A, Martínez C. Classical Hodgkin’s Lymphoma. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook. Cham: Springer International Publishing; 2019. pp. 653-62. [DOI: 10.1007/978-3-030-02278-5_88] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 137 |
Redondo AM, Valcárcel D, González‐rodríguez AP, Suárez‐lledó M, Bello JL, Canales M, Gayoso J, Colorado M, Jarque I, Campo R, Arranz R, Terol MJ, Rifón JJ, Rodríguez MJ, Ramírez MJ, Castro N, Sánchez A, López‐jiménez J, Montes‐moreno S, Briones J, López A, Palomera L, López‐guillermo A, Caballero D, Martín A; the Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO). Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group. Br J Haematol 2018. [DOI: 10.1111/bjh.15713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 138 |
Damlaj M, Snnallah M, Alhejazi A, Ghazi S, Alahmari B, Alaskar A, Al-Zahrani M. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World J Transplantation 2018; 8(7): 252-261 [PMID: 30596032 DOI: 10.5500/wjt.v8.i7.252] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 139 |
Damlaj M, Snnallah M, Alhejazi A, Ghazi S, Alahmari B, Alaskar A, Al-zahrani M. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. WJT 2018;8:252-61. [DOI: 10.5500/wjt.v8.i7.000] [Reference Citation Analysis]
|
| 140 |
Zitzer NC, Garzon R, Ranganathan P. Toll-Like Receptor Stimulation by MicroRNAs in Acute Graft-vs.-Host Disease. Front Immunol 2018;9:2561. [PMID: 30455702 DOI: 10.3389/fimmu.2018.02561] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 141 |
Lee SE, Park SS, Jeon YW, Yoon JH, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Lee JW. Optimal conditioning regimen for haplo-identical stem cell transplantation in adult patients with acquired severe aplastic anemia: Prospective de-escalation study of TBI and ATG dose. Am J Hematol 2018;93:1368-75. [PMID: 30117176 DOI: 10.1002/ajh.25257] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 142 |
Ruiz MA, Kaiser Junior RL, Piron-Ruiz L, Peña-Arciniegas T, Saran PS, De Quadros LG. Hematopoietic stem cell transplantation for Crohn's disease: Gaps, doubts and perspectives. World J Stem Cells 2018;10:134-7. [PMID: 30397423 DOI: 10.4252/wjsc.v10.i10.134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 143 |
Marques ADCB, Szczepanik AP, Machado CAM, Santos PND, Guimarães PRB, Kalinke LP. Hematopoietic stem cell transplantation and quality of life during the first year of treatment. Rev Lat Am Enfermagem 2018;26:e3065. [PMID: 30379249 DOI: 10.1590/1518-8345.2474.3065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 144 |
Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis 2018;20:e12994. [PMID: 30195271 DOI: 10.1111/tid.12994] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 145 |
Kyriakou C, Boumendil A, Finel H, Nn Norbert Schmitz, Andersen NS, Blaise D, Chevallier P, Browne P, Malladi R, Niederwieser D, Pagliuca A, Kroschinsky F, Montoto S, Dreger P; EBMT Lymphoma Working Party. The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party. Biol Blood Marrow Transplant 2019;25:86-93. [PMID: 30219698 DOI: 10.1016/j.bbmt.2018.08.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 146 |
Escudero A, Martínez-Romera I, Fernández L, Valentín J, González-Vicent M, Vicario JL, Madero-Jarabo R, Diaz MÁ, Pérez-Martínez A. Donor KIR Genotype Impacts on Clinical Outcome after T Cell-Depleted HLA Matched Related Allogeneic Transplantation for High-Risk Pediatric Leukemia Patients. Biol Blood Marrow Transplant 2018;24:2493-500. [PMID: 30145228 DOI: 10.1016/j.bbmt.2018.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 147 |
Marani C, Raiola AM, Morbelli S, Dominietto A, Ferrarazzo G, Avenoso D, Giannoni L, Varaldo R, Gualandi F, Grazia D, Lamparelli T, Bregante S, Van Lint MT, Ibatici A, Bovis F, Lemoli RM, Gobbi M, Bacigalupo A, Angelucci E. Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography. Biol Blood Marrow Transplant 2018;24:2501-8. [PMID: 30041010 DOI: 10.1016/j.bbmt.2018.07.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 148 |
Yang B, Yu R, Cai L, Bin Guo, Chen H, Zhang H, He P, Lu X. Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis. Bone Marrow Transplant 2019;54:99-122. [PMID: 29988061 DOI: 10.1038/s41409-018-0239-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 149 |
Kamel AM, El-Fishawi S, Rasekh EO, Radwan ER, Zeidan A, El-Said A, Zaky AH, Abdelfattah M, Refaat A, Abdelfattah R. Variability of contribution of vitamin D receptor gene polymorphisms to outcome of HLA-matched sibling allogeneic bone marrow transplantation. Leuk Lymphoma 2018;59:2963-72. [PMID: 29972092 DOI: 10.1080/10428194.2018.1459608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 150 |
Delia M, Carluccio P, Mestice A, Brunetti C, Albano F, Specchia G. Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients. J Immunol Res 2018;2018:9325261. [PMID: 30069492 DOI: 10.1155/2018/9325261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 151 |
Abusarah J, Khodayarian F, Cui Y, El-kadiry AE, Rafei M. Thymic Rejuvenation: Are We There Yet? Gerontology 2018. [DOI: 10.5772/intechopen.74048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 152 |
Guan L, Li X, Wei H, Gu Z, Zhao S, Zhu C, Yang N, Wang F, Luo L, Gao Z, Huang W, Li H, Wang Q, Liu D, Wu X, Gao C. T Cell-Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation for Treatment of T-Lymphoblastic Lymphoma. Ann Transplant 2018;23:427-33. [PMID: 29930241 DOI: 10.12659/AOT.909122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 153 |
Liu APY, Lee PPW, Kwok JSY, Leung RYY, Chiang AKS, Ha SY, Cheuk DKL, Chan GCF. Selective T cell-depleted haploidentical hematopoietic stem cell transplantation for relapsed/refractory neuroblastoma. Pediatr Transplant 2018;:e13240. [PMID: 29921011 DOI: 10.1111/petr.13240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 154 |
Ruiz MA, Kaiser RL, Piron – Ruiz L, Peña-arciniegas T, Castiglioni L, Samara Saran P, De Quadros LG, Gouvea Faria MA, Siqueira RC, Liedtke Kaiser FS, Comenalli Marques JF. Crohn’s disease patients effectively mobilize peripheral blood stem cells to perform autologous haematopoietic stem cell transplantation.. [DOI: 10.1101/348763] [Reference Citation Analysis]
|
| 155 |
Canaani J, Labopin M, Huang XJ, Arcese W, Ciceri F, Blaise D, Irrera G, Corral LL, Bruno B, Santarone S, Van Lint MT, Vitek A, Esteve J, Mohty M, Nagler A. T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Am J Hematol 2018;93:736-44. [PMID: 29498106 DOI: 10.1002/ajh.25082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 156 |
Kisch AM, Forsberg A. Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study. Open Nurs J 2018;12:46-57. [PMID: 29844844 DOI: 10.2174/1874434601812010046] [Reference Citation Analysis]
|
| 157 |
Carella AM, Corradini P, Mussetti A, Ricardi U, Vitolo U, Viviani S. Treatment of classical Hodgkin lymphoma in the era of brentuximab vedotin and immune checkpoint inhibitors. Ann Hematol 2018;97:1301-15. [PMID: 29802458 DOI: 10.1007/s00277-018-3366-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 158 |
Sureda A, Dreger P, Bishop MR, Kroger N, Porter DL. Prevention and treatment of relapse after stem cell transplantation in lymphoid malignancies. Bone Marrow Transplant 2019;54:17-25. [PMID: 29795433 DOI: 10.1038/s41409-018-0214-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 159 |
Mohty M, Duarte RF, Kuball J, Bader P, Basak GW, Bonini C, Carreras E, Chabannon C, Dufour C, Gennery A, Lankester A, Lanza F, Ljungman P, Montoto S, Nagler A, Snowden JA, Styczynski J, Sureda A, Kröger N. Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation. Bone Marrow Transplant 2018;53:1548-52. [DOI: 10.1038/s41409-018-0190-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 160 |
Bhella S, Majhail NS, Betcher J, Costa LJ, Daly A, Dandoy CE, Defilipp Z, Doan V, Gulbis A, Hicks L, Juckett M, Khera N, Krishnan A, Selby G, Shah NN, Stricherz M, Viswabandya A, Bredeson C, Seftel MD. Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 2018;24:909-13. [DOI: 10.1016/j.bbmt.2018.01.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 161 |
Wang HD, Fidder SA, Miller DT, Furtmüller GJ, Ahmadi AR, Nägele F, Lopez J, Quan A, Budihardjo J, Lough DM, Akpinarli B, Etra JW, Vasilic D, Raimondi G, Lee WA, Montgomery RA, Sun Z, Brandacher G. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation. Transplantation 2018;102:593-600. [DOI: 10.1097/tp.0000000000002070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 162 |
Czerw T, Labopin M, Giebel S, Socié G, Volin L, Fegueux N, Masszi T, Blaise D, Chaganti S, Cornelissen JJ, Passweg J, Maertens J, Itälä-Remes M, Wu D, Mohty M, Nagler A. Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT. Cancer 2018;124:2523-33. [PMID: 29603136 DOI: 10.1002/cncr.31354] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 163 |
Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, Dufour C, Kröger N, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2018;53:1139-48. [PMID: 29540849 DOI: 10.1038/s41409-018-0153-1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 164 |
Wallek S, Senn-Malashonak A, Vogt L, Schmidt K, Bader P, Banzer W. Impact of the initial fitness level on the effects of a structured exercise therapy during pediatric stem cell transplantation. Pediatr Blood Cancer 2018;65. [PMID: 29049845 DOI: 10.1002/pbc.26851] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 165 |
Baron F, Ruggeri A, Beohou E, Labopin M, Sanz G, Milpied N, Michallet M, Bacigalupo A, Blaise D, Sierra J, Socié G, Cornelissen JJ, Schmid C, Giebel S, Gorin NC, Esteve J, Ciceri F, Savani BN, Mohty M, Gluckman E, Nagler A. RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT. Oncotarget 2016;7:43027-38. [PMID: 27250025 DOI: 10.18632/oncotarget.9599] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 166 |
Bozdağ SC, Yüksel MK, Demirer T. Adult Stem Cells and Medicine. Advances in Experimental Medicine and Biology 2018. [DOI: 10.1007/5584_2018_184] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 167 |
Halter JP, Worel N, Passweg JR. Donor/Recipient Selection, Work-Up, and Safety. Establishing a Hematopoietic Stem Cell Transplantation Unit 2018. [DOI: 10.1007/978-3-319-59358-6_10] [Reference Citation Analysis]
|
| 168 |
Locatelli F, Strocchio L. Indications for Hematopoietic Stem Cell Transplantation in Children. Establishing a Hematopoietic Stem Cell Transplantation Unit 2018. [DOI: 10.1007/978-3-319-59358-6_6] [Reference Citation Analysis]
|
| 169 |
Babic A, Trigoso E. Cell Source and Apheresis. The European Blood and Marrow Transplantation Textbook for Nurses 2018. [DOI: 10.1007/978-3-319-50026-3_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 170 |
Gratwohl A. Global Perspectives on Hematopoietic Stem Cell Transplants (HSCTs). Establishing a Hematopoietic Stem Cell Transplantation Unit 2018. [DOI: 10.1007/978-3-319-59358-6_1] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 171 |
Epperla N, Hamadani M, Horowitz MM. Indications for Allogeneic Hematopoietic Stem Cell Transplantation in Adults. Establishing a Hematopoietic Stem Cell Transplantation Unit 2018. [DOI: 10.1007/978-3-319-59358-6_7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 172 |
Kodera Y. Paving the Way to Hematopoietic Stem Transplantation Worldwide. Establishing a Hematopoietic Stem Cell Transplantation Unit 2018. [DOI: 10.1007/978-3-319-59358-6_21] [Reference Citation Analysis]
|
| 173 |
Galgano L, Hutt D. HSCT: How Does It Work? The European Blood and Marrow Transplantation Textbook for Nurses 2018. [DOI: 10.1007/978-3-319-50026-3_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 174 |
Okamoto S. Current indication for hematopoietic cell transplantation in adults. Hematology/Oncology and Stem Cell Therapy 2017;10:178-83. [DOI: 10.1016/j.hemonc.2017.05.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 175 |
Gagelmann N, Ayuk F, Wolschke C, Kröger N. Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in Allogeneic Stem Cell Transplantation: Systematic Literature Review and Network Meta-Analysis. Biology of Blood and Marrow Transplantation 2017;23:2184-91. [DOI: 10.1016/j.bbmt.2017.08.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 176 |
Tekgündüz E, Arat M, Göker H, Özdoğu H, Kaynar L, Çağırgan S, Erkurt MA, Vural F, Kiki İ, Altuntaş F, Demirkan F; Turkish Society of Apheresis (TSA). Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA). Transfus Apher Sci 2017;56:845-9. [PMID: 29153306 DOI: 10.1016/j.transci.2017.11.025] [Reference Citation Analysis]
|
| 177 |
Schroeder T, Rautenberg C, Haas R, Germing U, Kobbe G. Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation. Int J Hematol 2018;107:138-50. [DOI: 10.1007/s12185-017-2364-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 178 |
Tekgündüz E, Demirkan F, Vural F, Göker H, Özdoğu H, Kiki İ, Aydoğdu İ, Kaynar L, Erkurt MA, Çağırgan S, Beşışık S, Dağdaş S, Koca E, Kadıköylü G, Gündüz E, Yılmaz M, Beköz H, Ural AU, Baştürk A, Arat M, Albayrak M, Öztürk E, Akyol A, Bolaman AZ, Nevruz O, Özkan HA, Özgür G, Altuntaş F. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Transfus Apher Sci 2017;56:804-8. [PMID: 29153305 DOI: 10.1016/j.transci.2017.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 179 |
Delia M, Pastore D, Carluccio P, Pasciolla C, Ricco A, Rossi AR, Casieri P, Mestice A, Albano F, Specchia G. FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients. Clinical Lymphoma Myeloma and Leukemia 2017;17:767-73. [DOI: 10.1016/j.clml.2017.06.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 180 |
Heneghan C, Smilow E, Tanhehco Y, Jin Z, Cofnas P, Schwartz S, Patel N, Carberry D, Silverman J, Huynh P, Hagan B, Tobin K, Bhatia M, George D, Garvin J, Satwani P. Safety of hematopoietic cell infusion in children with malignant and non-malignant diseases. Pediatr Transplant 2017;21. [PMID: 28845921 DOI: 10.1111/petr.13038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 181 |
Martínez C, Gayoso J, Canals C, Finel H, Peggs K, Dominietto A, Castagna L, Afanasyev B, Robinson S, Blaise D, Corradini P, Itälä-remes M, Bermúdez A, Forcade E, Russo D, Potter M, Mcquaker G, Yakoub-agha I, Scheid C, Bloor A, Montoto S, Dreger P, Sureda A; on behalf of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation. JCO 2017;35:3425-32. [DOI: 10.1200/jco.2017.72.6869] [Cited by in Crossref: 110] [Cited by in F6Publishing: 116] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 182 |
Berro M, Arbelbide JA, Rivas MM, Basquiera AL, Ferini G, Vitriu A, Foncuberta C, Fernandez Escobar N, Requejo A, Milovic V, Yantorno S, Szelagoswki M, Martinez Rolon J, Bentolila G, Garcia JJ, Garcia P, Caeiro G, Castro M, Jaimovich G, Palmer S, Trucco JI, Bet LA, Shaw BE, Kusminsky GD. Hematopoietic Cell Transplantation–Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2017;23:1646-50. [DOI: 10.1016/j.bbmt.2017.06.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 183 |
Persoon S, Chinapaw MJM, Buffart LM, Brug J, Kersten MJ, Nollet F. Lessons learnt from a process evaluation of an exercise intervention in patients treated with autologous stem cell transplantation. Eur J Cancer Care (Engl) 2018;27. [PMID: 28960542 DOI: 10.1111/ecc.12779] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 184 |
Davulcu EA, Sahin F, Saydam G. Transfusion in Transplantation. Transfusion Medicine and Scientific Developments 2017. [DOI: 10.5772/intechopen.69260] [Reference Citation Analysis]
|
| 185 |
Grubovic RM, Georgievski B, Cevreska L, Genadieva-Stavric S, Grubovic MR. Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood. Open Access Maced J Med Sci 2017;5:324-31. [PMID: 28698751 DOI: 10.3889/oamjms.2017.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 186 |
Picardi A, Arcese W, Pollichieni S, Di Piazza F, Mangione I, Gallina AM, Cerretti R, Cudillo L, De Angelis G, Mengarelli A, Dentamaro T, Tirindelli MC, Chierichini A, Ferrari A, Marciano R, Andreani M, Bonifazi F, Sacchi N. The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy: SEARCH STRATEGY AND TRANSPLANT EFFICIENCY. Transfusion 2017;57:1734-43. [DOI: 10.1111/trf.14131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 187 |
Giaccone L, Festuccia M, Zallio F, Sorasio R, Brunello L, Maffini E, Dellacasa C, Passera R, Iovino G, Aydin S, Boccadoro M, Vitolo U, Mordini N, Pini M, Busca A, Bruno B. Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma. Bone Marrow Transplant 2017;52:1208-11. [PMID: 28581461 DOI: 10.1038/bmt.2017.99] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 188 |
Elemary M, Seghatchian J, Stakiw J, Bosch M, Sabry W, Goubran H. Transfusion challenges in hematology oncology and hematopoietic stem cell transplant - Literature review and local experience. Transfus Apher Sci 2017;56:317-21. [PMID: 28642120 DOI: 10.1016/j.transci.2017.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 189 |
Garry GA, Garry DJ. Cell Therapy and Heart Failure. In: Garry DJ, Wilson RF, Vlodaver Z, editors. Congestive Heart Failure and Cardiac Transplantation. Cham: Springer International Publishing; 2017. pp. 401-13. [DOI: 10.1007/978-3-319-44577-9_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 190 |
Arruda L, Oliveira M, Malmegrim K, Gluckman E, Farge D. Autologous Hematopoietic Cell Transplants for Autoimmune Diseases: Specific Diseases and Controversies. Hematopoietic Cell Transplants 2017. [DOI: 10.1017/9781316335727.058] [Reference Citation Analysis]
|
| 191 |
Hematopoietic Cell Transplants for Non-Neoplastic Diseases. Hematopoietic Cell Transplants 2017. [DOI: 10.1017/9781316335727.053] [Reference Citation Analysis]
|
| 192 |
Santoro N, Ruggeri A, Labopin M, Bacigalupo A, Ciceri F, Gülbaş Z, Huang H, Afanasyev B, Arcese W, Wu D, Koc Y, Tischer J, Santarone S, Giebel S, Mohty M, Nagler A. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. J Hematol Oncol 2017;10:113. [PMID: 28558762 DOI: 10.1186/s13045-017-0480-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 193 |
Patriarca F, Giaccone L, Onida F, Castagna L, Sarina B, Montefusco V, Mussetti A, Mordini N, Maino E, Greco R, Peccatori J, Festuccia M, Zaja F, Volpetti S, Risitano A, Bassan R, Corradini P, Ciceri F, Fanin R, Baccarani M, Rambaldi A, Bonifazi F, Bruno B. New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? Expert Opin Biol Ther 2017;17:821-36. [PMID: 28506131 DOI: 10.1080/14712598.2017.1324567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 194 |
Xiao X, Huang H, Chen J, Jiang Y, Zhang L, Xu Y, Xu T, Chen X, Li C, Jin Z, Ruan J, Wu D. Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 2017;58:2957-61. [DOI: 10.1080/10428194.2017.1317096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 195 |
Kharfan-Dabaja MA, El-Jurdi N, Ayala E, Kanate AS, Savani BN, Hamadani M. Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas? Bone Marrow Transplant 2017;52:1487-94. [PMID: 28368373 DOI: 10.1038/bmt.2017.55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 196 |
Snowden JA, McGrath E, Duarte RF, Saccardi R, Orchard K, Worel N, Kuball J, Chabannon C, Mohty M. JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement. Bone Marrow Transplant 2017;52:1367-71. [PMID: 28346416 DOI: 10.1038/bmt.2017.54] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 197 |
Gratwohl A, Sureda A, Cornelissen J, Apperley J, Dreger P, Duarte R, Greinix HT, Mc Grath E, Kroeger N, Lanza F, Nagler A, Snowden JA, Niederwieser D, Brand R; for the European Society for Blood and Marrow Transplantation (EBMT). Alloreactivity: the Janus-face of hematopoietic stem cell transplantation. Leukemia 2017;31:1752-9. [DOI: 10.1038/leu.2017.79] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 198 |
Swart JF, Delemarre EM, van Wijk F, Boelens J, Kuball J, van Laar JM, Wulffraat NM. Haematopoietic stem cell transplantation for autoimmune diseases. Nat Rev Rheumatol 2017;13:244-56. [DOI: 10.1038/nrrheum.2017.7] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 199 |
Yasar N, Akin S. Evaluation of Quality of Life and Care Needs of Turkish Patients Undergoing Hematopoietic Stem Cell Transplantation. Nurs Res Pract 2016;2016:9604524. [PMID: 28116155 DOI: 10.1155/2016/9604524] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 200 |
Deneys V, Fabry A, Van Hooydonk M, Sonet A, André M, Bourgeois M, Botson F. Efficiency of autologous stem cell collection: Comparison of three different cell separators. Transfus Apher Sci 2017;56:35-8. [PMID: 28111240 DOI: 10.1016/j.transci.2016.12.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 201 |
Törlén J, Remberger M, Le Blanc K, Ljungman P, Mattsson J. Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions. Biol Blood Marrow Transplant 2017;23:677-83. [PMID: 28063962 DOI: 10.1016/j.bbmt.2017.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 202 |
Yüksel MK, Demirer T. Toxicity of Conditioning Regimens in Haploidentical SCT. Stem Cell Biology and Regenerative Medicine 2017. [DOI: 10.1007/978-3-319-65319-8_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 203 |
Zecca M, Comoli P. Applications of Haploidentical SCT in Pediatric Patients. Stem Cell Biology and Regenerative Medicine 2017. [DOI: 10.1007/978-3-319-65319-8_11] [Reference Citation Analysis]
|
| 204 |
Parody R, Sureda A. Outcome of Haploidentical Stem Cell Transplantation in Patients with Lymphoma. Stem Cell Biology and Regenerative Medicine 2017. [DOI: 10.1007/978-3-319-65319-8_9] [Reference Citation Analysis]
|
| 205 |
Marsh J, Gandhi S, Mufti G. Immunosuppressive Therapy for Aplastic Anemia. Congenital and Acquired Bone Marrow Failure 2017. [DOI: 10.1016/b978-0-12-804152-9.00006-3] [Reference Citation Analysis]
|
| 206 |
Baron F, Mohty M, Blaise D, Socié G, Labopin M, Esteve J, Ciceri F, Giebel S, Gorin NC, Savani BN, Schmid C, Nagler A. Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica 2017;102:224-34. [PMID: 27927772 DOI: 10.3324/haematol.2016.148510] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 207 |
Onuoha C, Arshad J, Astle J, Xu M, Halene S. Novel Developments in Leukopenia and Pancytopenia. Primary Care: Clinics in Office Practice 2016;43:559-73. [DOI: 10.1016/j.pop.2016.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 208 |
Genadieva-stavrik S, Boumendil A, Dreger P, Peggs K, Briones J, Corradini P, Bacigalupo A, Socié G, Bonifazi F, Finel H, Velardi A, Potter M, Bruno B, Castagna L, Malladi R, Russell N, Sureda A. Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Annals of Oncology 2016;27:2251-7. [DOI: 10.1093/annonc/mdw421] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 209 |
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, Löwenberg B, Bloomfield CD. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017;129:424-47. [PMID: 27895058 DOI: 10.1182/blood-2016-08-733196] [Cited by in Crossref: 3010] [Cited by in F6Publishing: 3258] [Article Influence: 430.0] [Reference Citation Analysis]
|
| 210 |
Schroeder T, Rautenberg C, Haas R, Kobbe G. Hypomethylating agents after allogeneic blood stem cell transplantation. Stem Cell Investig 2016;3:84. [PMID: 28066786 DOI: 10.21037/sci.2016.11.04] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 211 |
Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M. Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2017;52:191-6. [PMID: 27819687 DOI: 10.1038/bmt.2016.258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 212 |
Katsanis E, Sapp LN, Pelayo-Katsanis L, Whitney K, Zeng Y, Kopp LM. Alternative Donor Hematopoietic Cell Transplantation Conditioned With Myeloablative Busulfan, Fludarabine, and Melphalan is Well Tolerated and Effective Against High-risk Myeloid Malignancies. J Pediatr Hematol Oncol 2016;38:e315-8. [PMID: 27467368 DOI: 10.1097/MPH.0000000000000621] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 213 |
Winkelmann N, Desole M, Hilgendorf I, Ernst T, Sayer HG, Kunert C, Mügge L, Hochhaus A, Scholl S. Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients. J Cancer Res Clin Oncol 2016;142:2603-10. [DOI: 10.1007/s00432-016-2270-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 214 |
Wirths S, Bethge W, Henes JC. [Allogeneic stem cell transplantation : An option for autoimmune diseases?]. Z Rheumatol 2016;75:780-5. [PMID: 27596146 DOI: 10.1007/s00393-016-0194-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 215 |
Jauregui-Amezaga A, Rovira M, López A, Marín P, Rodriguez S, Rimola J, Ordás I, Alfaro I, Panés J, Ricart E. Long-lasting Remission Induced by Syngeneic Haematopoietic Stem Cell Transplantation in a Patient with Refractory Crohn's Disease. J Crohns Colitis 2016;10:1122-4. [PMID: 26933030 DOI: 10.1093/ecco-jcc/jjw062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 216 |
Capria S, Barberi W, Perrone S, Ferretti A, Salaroli A, Annechini G, D'Elia GM, Foà R, Pulsoni A. Reappraising the timing of transplant for indolent non-Hodgkin lymphomas. Expert Rev Hematol 2016;9:951-64. [PMID: 27539362 DOI: 10.1080/17474086.2016.1226128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 217 |
Törlén J, Ringdén O, Garming-Legert K, Ljungman P, Winiarski J, Remes K, Itälä-Remes M, Remberger M, Mattsson J. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation. Haematologica 2016;101:1417-25. [PMID: 27662016 DOI: 10.3324/haematol.2016.149294] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 218 |
Sanderson F, Poullin P, Smith R, Nicolino-brunet C, Philip P, Chaib A, Costello R. Peripheral blood stem cells collection on spectra optia apheresis system using the continuous mononuclear cell collection protocol: A single center report of 39 procedures: Peripheral Blood Stem Cells Collection. J Clin Apheresis 2017;32:182-90. [DOI: 10.1002/jca.21485] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 219 |
Melve GK, Ersvaer E, Akkök ÇA, Ahmed AB, Kristoffersen EK, Hervig T, Bruserud Ø. Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor. Int J Mol Sci 2016;17:E1158. [PMID: 27447610 DOI: 10.3390/ijms17071158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 220 |
Horlock C, Skulte A, Mitra A, Stansfield A, Bhandari S, Ip W, Qasim W, Lowdell MW, Patel S, Friedetzky A, Purbhoo MA, Newton K. Manufacture of GMP-compliant functional adenovirus-specific T-cell therapy for treatment of post-transplant infectious complications. Cytotherapy 2016;18:1209-18. [PMID: 27424147 DOI: 10.1016/j.jcyt.2016.06.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 221 |
Ayuk FA, Kröger N. Stellenwert und Perspektiven der hämatopoetischen Stammzelltransplantation bei malignen hämatologischen Systemerkrankungen. Onkologe 2016;22:469-477. [DOI: 10.1007/s00761-016-0026-4] [Reference Citation Analysis]
|
| 222 |
Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M, Wang CB, Zhang X, Liu QF, Xia LH, Wang X, Huang XJ. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol 2016;175:265-74. [PMID: 27352174 DOI: 10.1111/bjh.14225] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 223 |
Dietrich S, Finel H, Martinez C, Tischer J, Blaise D, Chevallier P, Castagna L, Milpied N, Bacigalupo A, Corradini P, Mohty M, Sanz M, Hausmann A, Montoto S, Robinson S, Boumendil A, Sureda A, Dreger P; on behalf of the EBMT Lymphoma Working Party. Post-transplant cyclophosphamide-based haplo-identical transplantation as alternative to matched sibling or unrelated donor transplantation for non-Hodgkin lymphoma: a registry study by the European society for blood and marrow transplantation. Leukemia 2016;30:2086-9. [DOI: 10.1038/leu.2016.125] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 224 |
Mallet V, van Bömmel F, Doerig C, Pischke S, Hermine O, Locasciulli A, Cordonnier C, Berg T, Moradpour D, Wedemeyer H, Ljungman P; ECIL-5. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). Lancet Infect Dis 2016;16:606-17. [PMID: 27599653 DOI: 10.1016/S1473-3099(16)00118-3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 225 |
Boudin L, Gonçalves A, Sabatier R, Moretta J, Sfumato P, Asseeva P, Livon D, Bertucci F, Extra JM, Tarpin C, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Sobol H, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Viens P, Eisinger F, Chabannon C. Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2016;51:1082-6. [PMID: 27042835 DOI: 10.1038/bmt.2016.82] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 226 |
Greaves M. Leukaemia 'firsts' in cancer research and treatment. Nat Rev Cancer 2016;16:163-72. [PMID: 26911190 DOI: 10.1038/nrc.2016.3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 227 |
Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, Bouzas LF, Confer D, Greinix H, Horowitz M. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant. 2016;51:778-785. [PMID: 26901703 DOI: 10.1038/bmt.2016.18] [Cited by in Crossref: 219] [Cited by in F6Publishing: 224] [Article Influence: 31.3] [Reference Citation Analysis]
|
| 228 |
Tekgündüz E, Kaynar L, Göker H, Kaya AH, Turak EE, Eliaçık E, Kayıkçı Ö, Çetin M, Büyükaşık Y, Eser B, Altuntaş F. Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice. Transfus Apher Sci 2016;54:41-7. [PMID: 26810140 DOI: 10.1016/j.transci.2016.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 229 |
Bakhuraysah MM, Siatskas C, Petratos S. Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality? Stem Cell Res Ther 2016;7:12. [PMID: 26772391 DOI: 10.1186/s13287-015-0272-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 230 |
Rashidi A, Ebadi M, Cashen AF. Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis. Bone Marrow Transplant 2016;51:521-8. [PMID: 26726948 DOI: 10.1038/bmt.2015.332] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 231 |
Gratwohl A. The Role of Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia. Hematologic Malignancies 2016. [DOI: 10.1007/978-3-319-33198-0_12] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 232 |
Al Ustwani O, Gupta N, Bakhribah H, Griffiths E, Wang E, Wetzler M. Clinical updates in adult acute lymphoblastic leukemia. Crit Rev Oncol Hematol 2016;99:189-99. [PMID: 26777876 DOI: 10.1016/j.critrevonc.2015.12.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 233 |
Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JC; British Society for Standards in Haematology. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187-207. [PMID: 26568159 DOI: 10.1111/bjh.13853] [Cited by in Crossref: 341] [Cited by in F6Publishing: 385] [Article Influence: 42.6] [Reference Citation Analysis]
|
| 234 |
Marchand T, Lamy T, Finel H, Arcese W, Choquet S, Finke J, Huynh A, Irrera G, Karakasis D, Konopacki J, Lambert J, Michieli M, Schouten HC, Schroyens W, Sucak G, Tischer J, Vandenberghe E, Dreger P; on behalf of the Lymphoma Working Party of the EBMT. Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. Leukemia 2016;30:1201-4. [DOI: 10.1038/leu.2015.256] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 235 |
Schroeder T, Kobbe G. First Steps Towards Successful Post-Transplantation Therapy for Myeloid Malignancies after Allogeneic Blood Stem Cell Transplantation. Biol Blood Marrow Transplant 2015;21:1703-4. [PMID: 26277403 DOI: 10.1016/j.bbmt.2015.08.012] [Reference Citation Analysis]
|
| 236 |
Yerushalmi R, Shem-tov N, Danylesko I, Avigdor A, Nagler A, Shimoni A. Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies. Bone Marrow Transplant 2015;50:1526-35. [DOI: 10.1038/bmt.2015.174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 237 |
Parma M, Viganò C, Fumagalli M, Colnaghi F, Colombo A, Mottadelli F, Rossi V, Elli E, Terruzzi E, Belotti A, Cazzaniga G, Pogliani EM, Pioltelli P. Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission. Mediterr J Hematol Infect Dis 2015;7:e2015041. [PMID: 26075048 DOI: 10.4084/MJHID.2015.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 238 |
Duarte RF, Salgado M, Sánchez-Ortega I, Arnan M, Canals C, Domingo-Domenech E, Fernández-de-Sevilla A, González-Barca E, Morón-López S, Nogues N, Patiño B, Puertas MC, Clotet B, Petz LD, Querol S, Martinez-Picado J. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report. Lancet HIV 2015;2:e236-42. [PMID: 26423196 DOI: 10.1016/S2352-3018(15)00083-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 239 |
Dietrich S, Dreger P. Mantle cell lymphoma. Clinical Guide to Transplantation in Lymphoma 2015. [DOI: 10.1002/9781118863282.ch17] [Reference Citation Analysis]
|
| 240 |
Mayer K, Trubestein G. [On the causes and pathogenesis of so-called late epilepsy]. Med Welt. 1968;37:1951-1956. [PMID: 29214116 DOI: 10.1186/s40164-017-0092-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 241 |
Liu WP, Wu M, Zhang C, Xie Y, Song YQ, Wang XP, Zhu J. [Efficiency and safety of autologous hematopoietic stem cell transplantation for 19 cases with elderly lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2018;39:1033-6. [PMID: 30612408 DOI: 10.3760/cma.j.issn.0253-2727.2018.12.013] [Reference Citation Analysis]
|
